Clinical Trials

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


Bone Marrow Transplant

Allogeneic HCT Compared to Chemotherapy in Older AML Patients (2368)
Feasibility and Outcomes of Allogeneic Hematopoietic Cell Transplantation (HCT) Compared to Conventional Therapy for Older and Medically Infirm Patients Diagnosed with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes: A Prospective Observational Study
Status Conditions Phase Study ID
Recruiting Acute Myeloid Leukemia (AML)
Myelodysplastic Syndrome (MDS)
N/A 2368
NCT01929408
Summary

The purpose of this study is to compare treatment methods and outcomes of patients diagnosed with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).


Investigator
Mohamed Sorror, MD, MSc
Location    
Seattle Cancer Care Alliance 800-804-8824  
Eligibility Criteria (must meet the following to participate in this study)
  • Patients with new diagnoses of non-M3 AML or high-risk MDS who present for AML-like treatment that could plausibly produce a complete remission (CR); for example intensive induction chemotherapy, low dose single agent chemotherapy, hypo-methylation agent, or a similar therapy
  • Explicitly intend to establish follow-up care at one of the collaborating institutions.
  • Patients of ≥18 years of age and are being treated by the adult AML service.
  • Able to read and speak English.
  • Willing and able to provide informed consent.
Exclusions (conditions that would prevent participation in this study)
  • Patients of ≤17 years of age or who are ≥18 and receive treatment under the pediatric AML service.
  • Patients older than 80 years
  • Patients with <6 months projected survival due to active second malignancy or other medical problem.

Other exclusion criteria may apply.

Last Updated
July 21, 2014
See this trial at ClinicalTrials.gov
Access protocol and consent forms at Fred Hutchinson Cancer Research Center
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:
  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.